Browsing by Author Watts, Gerald F

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 14 of 14
Issue DateTitleAuthor(s)Citation
2014Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients with Statin Intolerance: The GAUSS-2 Randomized, Placebo-controlled Phase 3 Clinical Trial of EvolocumabSullivan, David; Bruckert, Eric; Cho, Leslie; Civeira, Fernando; Colquhoun, David; Dent, Ricardo; et al, Various; Knusel, Beat; Rosenson, Robert S; Stroes, Erik; Watts, Gerald F; School of Public Health: NH&MRC Clinical Trials CentreAnti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients with Statin Intolerance: The GAUSS-2 Randomized, Placebo-controlled Phase 3 Clinical Trial of Evolocumab, Journal of the American College of Cardiology, vol.63, 23, 2014,pp 2541-2548
2013An audit of pharmacists' knowledge of familial hypercholesterolaemia: Implications for community healthcareKrass, Ines; Bell, Damon; Hanson, Matthew; Jervis, Lee; Watts, Gerald F; PharmacyAn audit of pharmacists' knowledge of familial hypercholesterolaemia: Implications for community healthcare, Australian Pharmacist, vol.32, 7, 2013,pp 73-75
2014Cigarette smoking and albuminuria are associated with impaired arterial smooth muscle function in patients with type 2 diabetes mellitus: a FIELD substudyCelermajer, David; Harmer, Jason; Keech, Anthony (Tony); Skilton, Michael; Veillard, Anne-Sophie; Marwick, Thomas H; Meredith, Ian T; Watts, Gerald F; Central Clinical School: Medicine; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; Boden Institute; School of Public Health: NH&MRC Clinical Trials CentreCigarette smoking and albuminuria are associated with impaired arterial smooth muscle function in patients with type 2 diabetes mellitus: a FIELD substudy, Diabetes Research and Clinical Practice, vol.106, 2, 2014,pp 328-336
2015Clinical Guidelines on Hyperlipidaemia: Recent Developments, Future Challenges and the Need for an Australian ReviewChow, Clara Kayei; Keech, Anthony (Tony); Barter, Philip; Grenfell, Robert; Nicholls, Stephen; Sullivan, D; Tonkin, Andrew M; Watts, Gerald F; Western Clinical School: Medicine (Westmead); NH&MRC Clinical Trials CentreClinical Guidelines on Hyperlipidaemia: Recent Developments, Future Challenges and the Need for an Australian Review, Heart, Lung and Circulation, vol.24, 5, 2015,pp 495-502
2012Detection and care of familial hypercholesterolaemia in the community: is there a role for the pharmacist?Krass, Ines; Walker, Adrian; Watts, Gerald F; PharmacyDetection and care of familial hypercholesterolaemia in the community: is there a role for the pharmacist?, International Journal of Clinical Pharmacy, vol.34, 4, 2012,pp 501-505
2013Familial hypercholesterolaemia in children and adolescents: A new paediatric model of careSullivan, David; Coakley, John; Forbes, David A; Martin, Andrew C; Watts, Gerald F; Molecular BioscienceFamilial hypercholesterolaemia in children and adolescents: A new paediatric model of care, Journal of Paediatrics and Child Health, vol.49, 4, 2013,pp E263-E272
2011Familial hypercholesterolaemia: A model of care for AustralasiaBarter, Philip; Freeman, Lucinda; Krass, Ines; Sullivan, David; Trent, Ronald; Bishop, Warrick; Clifton, Peter M.; et al, various; George, Peter M.; Hamilton-Craig, Ian; O'Brien, Richard; Poplawski, Nicola; van Bockxmeer, Frank M.; Watts, Gerald F; Central Clinical School: Heart Research Institute; School of Public Health: Public Health; Pharmacy; Molecular Bioscience; Central Clinical School: MedicineFamilial hypercholesterolaemia: A model of care for Australasia, Atherosclerosis Supplements, vol.12, N/A, 2011,pp 221-263
2010Fenofibrate Concomitantly Decreases Serum Proprotein Convertase Subtilisin/Kexin Type 9 and Very-Low-Density Lipoprotein Particle Concentrations in Statin-treated Type 2 Diabetic PatientsRye, Kerry-Anne; Chan, Dick C.; Chew, G T; Hamilton, S J; Jenkins, Alicia J.; Lambert, Gilles; Watts, Gerald F; Central Clinical School: Heart Research InstituteFenofibrate Concomitantly Decreases Serum Proprotein Convertase Subtilisin/Kexin Type 9 and Very-Low-Density Lipoprotein Particle Concentrations in Statin-treated Type 2 Diabetic Patients, Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics, vol.12, 9,pp 752-756
2015Fenofibrate effects on arterial endothelial function in adults with type 2 diabetes mellitus: A FIELD substudyCelermajer, David; Harmer, Jason; Keech, Anthony (Tony); Skilton, Michael; Veillard, Anne-Sophie; Marwick, Thomas H; Meredith, Ian T; Watts, Gerald F; Central Clinical School: Medicine; Central Clinical School: Medicine; NH&MRC Clinical Trials Centre; Boden Institute; NH&MRC Clinical Trials CentreFenofibrate effects on arterial endothelial function in adults with type 2 diabetes mellitus: A FIELD substudy, Atherosclerosis, vol.242, 1, 2015,pp 295-302
2014A framework for bridging the gap in the care of familial hypercholesterolaemia in the community: pragmatic and economic perspectivesSullivan, David; Garton-Smith, Jacquie; O’Leary, Peter; Playford, David; Purchase, Sharon; Slattery, Mark; Vickery, Alistair; Watts, Gerald F; School of Public Health: NH&MRC Clinical Trials CentreA framework for bridging the gap in the care of familial hypercholesterolaemia in the community: pragmatic and economic perspectives, International Journal of Evidence-Based Healthcare, vol.12, 4, 2014,pp 244-254
2014Integrated guidance on the care of familial hypercholesterolemia from the International FH FoundationSullivan, David; Alonso, Rodrigo; Brown, W Virgil; Bruckert, Eric; Defesche, Joep; et al, Various; Gidding, Samuel; Lin, Khoo Kah; Livingston, Michael; Toth, Peter P; Watts, Gerald F; Wierzbicki, Anthony S; School of Public Health: NH&MRC Clinical Trials CentreIntegrated guidance on the care of familial hypercholesterolemia from the International FH Foundation, Journal of Clinical Lipidology, vol.8, 2, 2014,pp 148-172
2012INTERIM Guidelines for the Diagnosis and Management of Familial HypercholesterolaemiaSullivan, David; Hamilton-Craig, Ian; van Bockxmeer, Frank M.; Watts, Gerald F; Molecular BioscienceINTERIM Guidelines for the Diagnosis and Management of Familial Hypercholesterolaemia, Heart, Lung and Circulation (Print), vol.21, 3, 2012,pp 159-162
2012A New Model of Care for Familial Hypercholesterolaemia: What is the Role of Cardiology?Semsarian, Chris; Sullivan, David; Bishop, Warrick; Clifton, Peter M.; George, Peter M.; Hamilton-Craig, Ian; O'Brien, Richard; Poplawski, Nicola; Tonkin, Andrew; van Bockxmeer, Frank M.; Watts, Gerald F; Central Clinical School: Centenary Institute; School of Public Health: NH&MRC Clinical Trials CentreA New Model of Care for Familial Hypercholesterolaemia: What is the Role of Cardiology?, Heart, Lung and Circulation, vol.21, 9, 2012,pp 543-550
2010On Reducing Cardiovascular Disease to a Rarity: Clinical Strategies and their Cost-EffectivenessLewis, Barry; Sullivan, David; Watts, Gerald F; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreOn Reducing Cardiovascular Disease to a Rarity: Clinical Strategies and their Cost-Effectiveness, Heart, Lung and Circulation, vol.19, 4, 2010,pp 225-227